To expand a registry of patients for the study of the epidemiology, etiology, and degree of morbidity associated with gastroparesis.
The Gastroparesis Registry 2 (GpR 2) will enroll new patients and patients from the initial NIDDK Gastroparesis Clinical Research Consortium Gastroparesis Registry (GpR) of gastroparesis patients which was initiated in February 2007 and completed in March 2011. To continue to follow and expand the data collections of a well-characterized cohort to further define the natural history and clinical course of gastroparesis. To provide a reliable source for recruitment of well-characterized patients with gastroparesis for therapeutic clinical trials, pathophysiological, molecular, histopathologic, or other ancillary studies. These subsequent clinical trials or ancillary studies will be conducted under separate study protocols with separate consent processes.
Study Type
OBSERVATIONAL
Enrollment
506
University of Louisville
Louisville, Kentucky, United States
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
Massachusetts General Hospital-Digestive Healthcare Center
Boston, Massachusetts, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Temple University Hospital
Philadelphia, Pennsylvania, United States
Texas Tech University Health Sciences Center
El Paso, Texas, United States